<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Sai Parenterals Secures $5.82M Equity Investment from Marquee Investors</title>
    <link>https://www.taxtmi.com/news?id=48907</link>
    <description>Equity investment by a consortium of professional investors provides capital to support Sai Parenterals&#039; international expansion, targeted acquisitions of assets and intellectual property in regulated markets, and scaling of manufacturing capabilities to broaden its formulations and CDMO offerings while leveraging existing regulatory approvals at certain facilities to support exports.</description>
    <language>en-us</language>
    <pubDate>Wed, 09 Jul 2025 18:01:08 +0530</pubDate>
    <lastBuildDate>Wed, 09 Jul 2025 18:01:08 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=834848" rel="self" type="application/rss+xml"/>
    <item>
      <title>Sai Parenterals Secures $5.82M Equity Investment from Marquee Investors</title>
      <link>https://www.taxtmi.com/news?id=48907</link>
      <description>Equity investment by a consortium of professional investors provides capital to support Sai Parenterals&#039; international expansion, targeted acquisitions of assets and intellectual property in regulated markets, and scaling of manufacturing capabilities to broaden its formulations and CDMO offerings while leveraging existing regulatory approvals at certain facilities to support exports.</description>
      <category>News</category>
      <law>-</law>
      <pubDate>Wed, 09 Jul 2025 18:01:08 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/news?id=48907</guid>
    </item>
  </channel>
</rss>